Description | BAY 2402234 is a novel and selective dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 1.2 nM. | ||
---|---|---|---|
Targets |
| ||
In vitro | BAY 2402234 induces differentiation and inhibits proliferation in AML cell lines across multiple AML subtypes.[1] | ||
In vivo | BAY 2402234 shows strong monotherapy efficacy and induces differentiation in AML xenograft models in vivo.[1] |